HCPCS A4230: Infusion Set for External Insulin Pump, Non-Needle Cannula
HCPCS Level II code A4230 describes an infusion set for an external insulin pump using a non-needle cannula, intended as a durable medical supply for continuous subcutaneous insulin delivery; service type is insulin pump infusion supply and the typical site of service is outpatient or home-based diabetes management where patients use external insulin pumps for ongoing insulin administration.
Customize your policy alerts
Sign up for hcpcs A4230 policy alerts
Get alerted when payer policies referencing A4230 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
BUCA’s average commercial rate for HCPCS A4230 sits at $17.4, providing an industry reference point that is higher than most individual commercial payers listed. Blue Cross Blue Shield and Cigna exhibit moderate dispersion around their midpoints, while Aetna’s values are tightly clustered with a P75–P25 range of $10.2 ($12.0 − $1.8). UnitedHealth Group shows the narrowest spread among the given payers with a P75–P25 range of $7.5 ($63.0 − $55.5), indicating consistent upper-tier reimbursement levels.
Blue Cross Blue Shield has a P75–P25 range of $3.5 ($11.9 − $8.4), and Cigna’s interquartile spread is $9.9 ($13.5 − $4.6), reflecting greater variability in negotiated rates. Overall, dispersion is widest at Cigna and narrowest at UnitedHealth Group, with BUCA’s mean of $17.4 positioning it above the pooled means of most individual commercial carriers.